Skip to Content

RE 19 (Atenolol 25 mg)

Pill with imprint RE 19 is White, Round and has been identified as Atenolol 25 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..

Atenolol is used in the treatment of anxiety; alcohol withdrawal; angina; angina pectoris prophylaxis; esophageal variceal hemorrhage prophylaxis and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RE 19

Atenolol

Imprint
RE 19
Strength
25 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Cardioselective beta blockers
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ranbaxy Pharmaceuticals Inc.
Inactive Ingredients
magnesium carbonate, magnesium stearate, silicon dioxide colloidal, sodium lauryl sulfate, sodium starch glycolate type A potato, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
63304-0621 Ranbaxy Pharmaceuticals Inc.
53002-1108 Pharmedix (repackager)

Get help with Imprint Code FAQs.

Related Images for "RE 19"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.